Clinical Trials Browser

Phase 2 × Bronchial Neoplasms × Bevacizumab × Clear all

Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, Lung Diseases, Lung Neoplasms, Respiratory Tract Neoplasms, Thoracic Neoplasms

NCT04974879 2023-03-29

Osimertinib Combined With Bevacizumab in the Treatment Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions Metastatic Non-Small Cell Lung Cancer

Phase 2 Unknown

20 enrolled

Thoracic

Bronchial Neoplasms, Carcinoma, Non-Small-Cell Lung

Clinical Trials

Neo-DIANA: Neoadjuvant Treatment for EGFR Mutated Patients

Osimertinib Combined With Bevacizumab in the Treatment Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions Metastatic Non-Small Cell Lung Cancer